1
|
Ciftci O, Oguz F, Beytur A, Polat F, Altıntas R, Oguzturk H. Lycopene prevents experimental priapism against oxidative and nitrosative damage. Eur Rev Med Pharmacol Sci 2021; 25:5070. [PMID: 34486678 DOI: 10.26355/eurrev_202108_26511] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
The article "Lycopene prevents experimental priapism against oxidative and nitrosative damage, by O. Ciftci, F. Oguz, A. Beytur, F. Polat, R. Altıntas, H. Oguzturk, published in Eur Rev Med Pharmacol Sci 2014; 18 (21): 3320-3325-PMID: 25487946" has been withdrawn due to problems concerning authorship. The Publisher apologizes for any inconvenience this may cause. https://www.europeanreview.org/article/8034.
Collapse
Affiliation(s)
- O Ciftci
- Department of Medical Pharmacology, Inonu University, Faculty of Medicine, Malatya, Turkey
| | | | | | | | | | | |
Collapse
|
2
|
Oguz F, Pasau T, Reper P. A score combining early detection of cytokines accurately predicts COVID-19 severity and intensive care unit transfer: If early cytokine score results are available and to compare with existing severity scores and CT scan observations. Int J Infect Dis 2021; 104:752. [PMID: 33529706 PMCID: PMC7847183 DOI: 10.1016/j.ijid.2021.01.059] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/18/2020] [Accepted: 01/25/2021] [Indexed: 12/02/2022] Open
Affiliation(s)
- F Oguz
- Critical Care Department, CHU UCL Namur, Site Godinne, Av. Dr G. Therasse 1, 5530 Yvoir, Belgium.
| | - T Pasau
- Critical Care Department, CHU UCL Namur, Site Godinne, Av. Dr G. Therasse 1, 5530 Yvoir, Belgium.
| | - P Reper
- Critical Care Department, CHU UCL Namur, Site Godinne, Av. Dr G. Therasse 1, 5530 Yvoir, Belgium.
| |
Collapse
|
3
|
Oguz F, Erol A, Suleymanoglu M, Cinar C, Ciftci HS, Besisik SK. Experience of istanbul faculty of medicine bone marrow bank: periodical activity documentation. Hematol Transfus Cell Ther 2020. [DOI: 10.1016/j.htct.2020.09.116] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022] Open
|
4
|
Tufan A, Oguz F, Tufan F, Kekık C, Tarakcı FB, Sargın D, Kalayoglu Besısık S. Association of human leukocyte antigen groups with oral mucositis in patients undergoing bone marrow transplantation. Leuk Res 2019. [DOI: 10.1016/s0145-2126(19)30329-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
5
|
Mueller M, Boeckel J, Frese K, Haas J, Scheiner C, Oguz F, Kayvanpour E, Hassel D, Katus H, Meder B. P1453Regulation of essential myosin light chain phosphorylation in dilated cardiomyopathy. Eur Heart J 2017. [DOI: 10.1093/eurheartj/ehx502.p1453] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
6
|
Karadeniz MS, Ciftci HS, Tefik T, Mammadov O, Yazıcı H, Nane I, Turkmen A, Oguz F, Tugrul KM. Comparison of Two Different Inhalation Anesthetics on Grafted Kidney Function in Patients Undergoing Renal Transplantation Surgery: Desflurane or Sevoflurane? Transplant Proc 2017; 49:448-453. [PMID: 28340810 DOI: 10.1016/j.transproceed.2017.01.014] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022]
Abstract
BACKGROUND Anesthetic management of patients during renal transplantation is vitally important for ensuring proper functioning of kidneys that have undergone ischemia-reperfusion damage. The goal of this prospective study was to compare the effects of 2 different inhalation agents (sevoflurane and desflurane) on grafted kidney function in renal transplantation surgery. METHODS Sixty-five patients who were scheduled for living donor renal transplantation were enrolled in the study. General anesthesia was performed on all patients. Thirty-five pairs of recipients and donors were anesthetized with sevoflurane (group S) and 30 pairs of recipients and donors were anesthetized with desflurane (group D). Each patient's demographic characteristics, immunologic and clinical data, and hemodynamic parameters were recorded. The estimated glomerular filtration rate was calculated in the preoperative period and on postoperative days 1 and 7. The blood samples were collected before the operation and on postoperative days 1 and 7 for measurement of serum creatinine, neutrophil gelatinase-associated lipocalin, and interleukin 18. RESULTS There were no significant differences in demographic characteristics or immunologic data between group D and group S. Intraoperative heart rate and mean arterial blood pressure were the same between groups. Creatinine, estimated glomerular filtration rate, neutrophil gelatinase-associated lipocalin, and interleukin 18 values did not differ between groups (P > .05) in the preoperative period and postoperative days 1 and 7. CONCLUSIONS Sevoflurane and desflurane had no adverse effects on grafted kidney functions according to short-term graft outcomes in patients undergoing living donor renal transplantation.
Collapse
Affiliation(s)
- M S Karadeniz
- Department of Anesthesiology, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey.
| | - H S Ciftci
- Department of Medical Biology, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey
| | - T Tefik
- Department of Urology, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey
| | - O Mammadov
- Department of Anesthesiology, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey
| | - H Yazıcı
- Department of Nephrology, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey
| | - I Nane
- Department of Urology, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey
| | - A Turkmen
- Department of Nephrology, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey
| | - F Oguz
- Department of Medical Biology, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey
| | - K M Tugrul
- Department of Anesthesiology, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey
| |
Collapse
|
7
|
Altintas R, Ciftci O, Aydin M, Akpolat N, Oguz F, Beytur A. Quercetin prevents docetaxel-induced testicular damage in rats. Andrologia 2014; 47:248-56. [DOI: 10.1111/and.12253] [Citation(s) in RCA: 24] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 01/04/2014] [Indexed: 12/01/2022] Open
Affiliation(s)
- R. Altintas
- Department of Urology; Inonu University School of Medicine; Malatya Turkey
| | - O. Ciftci
- Department of Pharmacology; Inonu University School of Medicine; Malatya Turkey
| | - M. Aydin
- Department of Obstetrics and Gynecology; Firat University School of Veterinary Medicine; Elazığ Turkey
| | - N. Akpolat
- Department of Pathology; Inonu University School of Medicine; Malatya Turkey
| | - F. Oguz
- Department of Urology; Inonu University School of Medicine; Malatya Turkey
| | - A. Beytur
- Department of Urology; Inonu University School of Medicine; Malatya Turkey
| |
Collapse
|
8
|
Ciftci O, Oguz F, Beytur A, Polat F, Altıntas R, Oguzturk H. Lycopene prevents experimental priapism against oxidative and nitrosative damage. Eur Rev Med Pharmacol Sci 2014; 18:3320-3325. [PMID: 25487946] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/04/2023]
Abstract
OBJECTIVE Priapism is a persistent and often painful penile erection in the absence of sexual stimulation. It can cause progressive fibrosis, edema and drying of the erectile tissue and then it can lead to erectile dysfunction. Previous studies suggested that, neuronal nitric oxide levels increased during the priapism. High NO levels can result in the formation of reactive oxygen species (ROS) leading to oxidative stress in tissue and reproductive system. The aim of this study was to evaluate oxidative and nitrosative effects caused by priapism in cavernosal tissue and serum, and determinate beneficial effects of lycopene on ischemic priapism. MATERIALS AND METHODS 32 rats were randomly divided into four groups and the first group being as the control. In the second group, experimental ischemic priapism was formed for an hour and then 1hour reperfusion was provided. In the third group, lycopene was intraperitoneally given at the dose of 10 mg/kg. In the fourth group, lycopene were administered to rats with experimental priapism. RESULTS Priapism caused a significant increase in TBARS (thiobarbituric acid reactive substances) and NO levels and a significant decrease in the levels of GSH, CAT, GPx and SOD in serum and cavernosal tissue of rats. However, lycopene significantly increased GSH, CAT, GPx and SOD levels but decreased formation of TBARS production and NO in rats with priapism. CONCLUSIONS Our findings indicated that ischemic priapism lead to significant oxidative and nitrosative damage in cavernosal tissue and serum samples of rats. However lycopene treatment eliminates these negative effects induced by priapism. For this reason, we suggested that lycopene may be used in the treatment of priapism.
Collapse
Affiliation(s)
- O Ciftci
- Department of Medical Pharmacology, Inonu University, Faculty of Medicine, Malatya, Turkey.
| | | | | | | | | | | |
Collapse
|
9
|
Ciftci O, Cetin A, Aydin M, Kaya K, Oguz F. Fish oil, contained in eicosapentaenoic acid and docosahexaenoic acid, attenuates testicular and spermatological damage induced by cisplatin in rats. Andrologia 2013; 46:1161-8. [PMID: 24350676 DOI: 10.1111/and.12209] [Citation(s) in RCA: 22] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 10/26/2013] [Indexed: 01/29/2023] Open
Abstract
The aim of this study was to investigate the beneficial effects of the fish oil (FO) supplementation on oxidative stress, sperm characteristics and histological alterations in the male reproductive system of rats against cisplatin (CP) toxicity. The rats were divided randomly into 4 equal groups (control, FO, CP and FO + CP). FO was orally administered at the dose of 1 softgel per rat per day for 14 days and CP was intraperitoneally given at the dose of 7 mg kg(-1) with a single injection. In CP + FO group, they were applicated at the same doses and times. The results showed that CP caused a significant oxidative damage via induction of lipid peroxidation and reduction in the antioxidant defence system potency in the testis tissue. In addition, sperm motility and sperm concentration significantly decreased but the abnormal sperm rate and histopathological testicular damage increased with CP treatment. On the other hand, FO treatment prevented oxidative, histopathological and spermatological effects of CP and reversed side effects of CP. In conclusion, FO supplementation had significant beneficial effects against CP toxicity on male reproductive system and toxic effects of CP can be prevented by FO treatment. Therefore, it appears that fish oil may be useful for the prevention and treatment of cisplatin-induced reproductive system toxicity.
Collapse
Affiliation(s)
- O Ciftci
- Department of Pharmacology, Inonu University, Faculty of Medicine, Malatya, Turkey
| | | | | | | | | |
Collapse
|
10
|
Altintas R, Oguz F, Beytur A, Ediz C, Gunes A, Ozer A. Comparison of results after fluoroquinolones and combination therapies in type IIIA chronic prostatitis. Actas Urol Esp 2013; 37:619-24. [PMID: 23768504 DOI: 10.1016/j.acuro.2012.11.018] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/02/2012] [Accepted: 11/27/2012] [Indexed: 11/25/2022]
Abstract
PURPOSE We investigated retrospectively the clinical outcomes of the patients with type iii inflammatory chronic prostatitis, who were treated with fluoroquinolones with and without an α-blocker between 2009-2011. MATERIAL AND METHODS Diagnosis was established with medical history (symptoms presented longer than 3 months within previous 6 months), physical examination, Meares-Stamey test and the questionnaire of the NIH-CPSI. The responses to the treatment were assessed with uroflowmetry test and the questionnaire of NIH-CPSI at initial and after 4 weeks of the treatment. The patients with incomplete data and treatment and who treated with α-blockers and/or antibiotics in the period 4 weeks prior to the therapy started in our clinic and had any surgery of lower urinary tract previously were excluded. The patients were classified under 6 groups; group1=ciprofloxacin, group2=ofloxacin, group3=levofloxacin, group4=ciprofloxacin+tamsulosin, group5=ofloxacin+tamsulosin, group 6=levofloxacin+tamsulosin. Wilcoxon Signed Ranks and Kruskal Wallis test were used for comparison of results. Mann Whitney U test with Bonferroni correction made was used as posthoc (P<.05). RESULTS The median scores of NIH-CPSI decreased significantly in all groups (P<.05). Levofloxacin reduced the median total scores of NIH-CPSI more than ciprofloxacin and ofloxacin monotherapies. The combination therapies were better than antibiotic therapies alone and best result was obtained in levofloxacin+tamsulosin combination. CONCLUSION Tamsulosin+fluoroquinolone (especially tamsulosin+levofloxacin) combinations yielded better results in both NIH-CPSI scores and peak flow rates.
Collapse
|
11
|
Altintas R, Polat A, Parlakpinar H, Vardi N, Beytur A, Oguz F, Sagir M, Yildiz A, Duran ZR. The effect of melatonin on acetylsalicylic acid-induced kidney and testis damage. Hum Exp Toxicol 2013; 33:383-95. [DOI: 10.1177/0960327113506240] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/04/2023]
Abstract
The aim of this study was to evaluate the acute effect of high-dose acetylsalicylic acid (ASA) on kidney and testis, and the potential protective and therapeutic effects of melatonin on ASA-related pathology. A total of 40 rats were randomly divided into the following 5 groups ( n = 8): group 1: control, not given any drug; group 2: only 200 mg/kg ASA was given; group 3: 5 mg/kg melatonin was given 45 min before administering 200 mg/kg ASA; group 4: 5 mg/kg melatonin was given 45 min after administering 200 mg/kg ASA; and group 5: only 5 mg/kg melatonin was given. The histopathological changes and the biochemical findings; such as malondialdehyde (MDA), superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPX), reduced glutathione (GSH), and blood urea nitrogen (BUN) as well as serum creatinine (Cr) levels were evaluated. ASA significantly increased MDA levels in both kidney and testis, whereas it significantly decreased the values of SOD, CAT, GPX, and GSH in kidney and CAT levels in testis. Melatonin significantly decreased MDA levels in kidney and ameliorated it in testis, whereas it caused elevation in the levels of antioxidants. BUN and Cr levels were higher after ASA, whereas these levels were diminished after melatonin administration. The improvement obtained by melatonin on ASA-induced histological alterations was more prominent when it was used after ASA in kidney and before ASA in testis. In this study, we demonstrated the beneficial effect of melatonin on high-dose ASA-related pathology of kidney and testis for the first time.
Collapse
Affiliation(s)
- R Altintas
- Department of Urology, Medical Faculty, Inonu University, Malatya, Turkey
| | - A Polat
- Department of Physiology, Medical Faculty, Inonu University, Malatya, Turkey
| | - H Parlakpinar
- Department of Pharmacology, Medical Faculty, Inonu University, Malatya, Turkey
| | - N Vardi
- Department of Embriology and Histology, Medical Faculty, Inonu University, Malatya, Turkey
| | - A Beytur
- Department of Urology, Medical Faculty, Inonu University, Malatya, Turkey
| | - F Oguz
- Department of Urology, Medical Faculty, Inonu University, Malatya, Turkey
| | - M Sagir
- Department of Pharmacology, Medical Faculty, Inonu University, Malatya, Turkey
| | - A Yildiz
- Department of Embriology and Histology, Medical Faculty, Inonu University, Malatya, Turkey
| | - ZR Duran
- Department of Physiology, Medical Faculty, Inonu University, Malatya, Turkey
| |
Collapse
|
12
|
Dierselhuis MP, Spierings E, Drabbels J, Hendriks M, Alaez C, Alberú J, Alvarez MB, Burlingham W, Campos E, Christiaans M, Claas F, Fasano ME, Gerbase-DeLima M, Gervais T, Gorodezky C, Larriba J, Lardy NM, Latinne D, Morales-Buenrostro LE, Moreno MJ, Oguz F, Opelz G, Sergeant R, Tambutti M, Teper S, Tilanus M, Turkmen A, Warrens AN, Weimar W, Goulmy E. Minor H antigen matches and mismatches are equally distributed among recipients with or without complications after HLA identical sibling renal transplantation. ACTA ACUST UNITED AC 2013; 82:312-6. [DOI: 10.1111/tan.12209] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/23/2013] [Revised: 07/31/2013] [Accepted: 09/06/2013] [Indexed: 11/28/2022]
Affiliation(s)
- M. P. Dierselhuis
- Department of Immunohematology and Blood Transfusion; Leiden University Medical Center; Leiden; The Netherlands
| | - E. Spierings
- Department of Immunology; University Medical Center Utrecht; Utrecht; The Netherlands
| | - J. Drabbels
- Department of Immunohematology and Blood Transfusion; Leiden University Medical Center; Leiden; The Netherlands
| | - M. Hendriks
- Department of Immunohematology and Blood Transfusion; Leiden University Medical Center; Leiden; The Netherlands
| | - C. Alaez
- Department of Immunology & Immunogenetics; Instituto de Diagnostico y Referencia Epidemiologicos; Mexico City; Mexico
| | - J. Alberú
- Department of Transplantation; Instituto Nacional de Ciencias, Médicas y de la Nutrición; Mexico City; Mexico
| | - M. B. Alvarez
- Centro de Inmunología y Genética molecular; Buenos Aires; Argentina
| | - W. Burlingham
- Department of Surgery; University of Wisconsin; Madison; WI; USA
| | - E. Campos
- Universidade Federal de São Paulo and Associação Fundo de Incentivo à Pesquisa; São Paulo; Brazil
| | - M. Christiaans
- Department of Nephrology; Maastricht University Medical Center; Maastricht; The Netherlands
| | - F. Claas
- Department of Immunohematology and Blood Transfusion; Leiden University Medical Center; Leiden; The Netherlands
| | - M. E. Fasano
- Immunologia Trapianti c/o Genetica; Turin; Italy
| | - M. Gerbase-DeLima
- Universidade Federal de São Paulo and Associação Fundo de Incentivo à Pesquisa; São Paulo; Brazil
| | - T. Gervais
- Immunohaematology, Cliniques St. Luc; Université Catholique de Louvain; Brussels; Belgium
| | - C. Gorodezky
- Department of Immunology & Immunogenetics; Instituto de Diagnostico y Referencia Epidemiologicos; Mexico City; Mexico
| | - J. Larriba
- Histocompatibility and Immunogenetics-ICBME; Hospital Italiano de Buenos Aires; Buenos Aires; Argentina
| | - N. M. Lardy
- Sanquin-Diagnostic Services; Amsterdam; The Netherlands
| | - D. Latinne
- Immunohaematology, Cliniques St. Luc; Université Catholique de Louvain; Brussels; Belgium
| | - L.-E. Morales-Buenrostro
- Department of Nephrology and Mineral Metabolism; Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubiran; México City; Mexico
| | - M. J. Moreno
- Histocompatibility Laboratory; CEMIC-Centro de Educacion Medica e Investigaciones Clinicas Norberto Quirno; Buenos Aires; Argentina
| | - F. Oguz
- Department of Medical Biology, Medical Faculty of Istanbul; Istanbul University; Istanbul; Turkey
| | - G. Opelz
- Institute of Immunology; University of Heidelberg; Heidelberg; Germany
| | - R. Sergeant
- Immunology; Imperial College Healthcare NHS Trust; London; UK
| | - M. Tambutti
- Histocompatibility and Immunogenetics-ICBME; Hospital Italiano de Buenos Aires; Buenos Aires; Argentina
| | - S. Teper
- Histocompatibility Laboratory; CEMIC-Centro de Educacion Medica e Investigaciones Clinicas Norberto Quirno; Buenos Aires; Argentina
| | - M. Tilanus
- Transplantation Immunology, Tissue Typing Laboratory; Maastricht University Medical Center; Maastricht; The Netherlands
| | - A. Turkmen
- Department of Medical Biology, Medical Faculty of Istanbul; Istanbul University; Istanbul; Turkey
| | - A. N. Warrens
- Immunology; Imperial College Healthcare NHS Trust; London; UK
| | - W. Weimar
- Internal medicine; Erasmus Medical Center; Rotterdam; The Netherlands
| | - E. Goulmy
- Department of Immunohematology and Blood Transfusion; Leiden University Medical Center; Leiden; The Netherlands
| |
Collapse
|
13
|
Naumova E, Ivanova M, Pawelec G, Constantinescu I, Bogunia-Kubik K, Lange A, Oguz F, Ozdilli K, Franceschi C, Caruso C, Mishra M, Middleton D. 16thIHIW: Immunogenetics of Aging. Int J Immunogenet 2013; 40:77-81. [DOI: 10.1111/iji.12027] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/16/2012] [Revised: 11/12/2012] [Accepted: 11/12/2012] [Indexed: 01/22/2023]
Affiliation(s)
- E. Naumova
- Department of Clinical Immunology; University Hospital Alexandrovska; Sofia Bulgaria
| | - M. Ivanova
- Department of Clinical Immunology; University Hospital Alexandrovska; Sofia Bulgaria
| | - G. Pawelec
- Center for Medical Research; University of Tubingen; Tubingen Germany
| | - I. Constantinescu
- Fundeni Clinical Institute Centre for Immunogenetics and Virology; Bucharest Romania
| | - K. Bogunia-Kubik
- Department of Clinical Immunology; Ludwik Hirszfeld Institute of Immunology and Experimental Therapy; Wroclaw Poland
| | - A. Lange
- Department of Clinical Immunology; Ludwik Hirszfeld Institute of Immunology and Experimental Therapy; Wroclaw Poland
| | - F. Oguz
- Department of Medical Biology; Istanbul Medical Faculty, Istanbul University; Istanbul Turkey
| | - K. Ozdilli
- Department of Medical Biology; Istanbul Medical Faculty, Istanbul University; Istanbul Turkey
| | - C. Franceschi
- Department of Experimental Pathology; University of Bologna; Bologna Italy
| | - C. Caruso
- Dipartimento di Biopatologia e Metodologie Biomediche; Universit'a di Palermo; Palermo Italy
| | - M. Mishra
- National Reference Laboratory; New Delhi India
| | - D. Middleton
- Transplant Immunology; Royal Liverpool University Hospital; Liverpool UK
| |
Collapse
|
14
|
Oguz F, Ciftci O, Aydın M, Timurkaan N, Beytur A, Altıntas R, Parlakpinar H. Aminoguanidine prevents testicular damage-induced-2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in male rats. Andrologia 2012; 45:225-31. [DOI: 10.1111/j.1439-0272.2012.01334.x] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 05/30/2012] [Indexed: 12/27/2022] Open
Affiliation(s)
- F. Oguz
- Department of Urology; Faculty of Medicine; University of Inonu; Malatya; Turkey
| | - O. Ciftci
- Department of Pharmaceutical Toxicology; Faculty of Pharmacy; University of Inonu; Malatya; Turkey
| | - M. Aydın
- Department of Obstetric and Gynecology; Faculty of Veterinary Medicine; University of Firat; Elazığ; Turkey
| | - N. Timurkaan
- Vocational School of Health; University of Fırat; Elazig; Turkey
| | - A. Beytur
- Department of Urology; Faculty of Medicine; University of Inonu; Malatya; Turkey
| | - R. Altıntas
- Department of Urology; Faculty of Medicine; University of Inonu; Malatya; Turkey
| | - H. Parlakpinar
- Department of Pharmacology; Faculty of Medicine; University of Inonu; Malatya; Turkey
| |
Collapse
|
15
|
Seyhun Y, Mytilineos J, Turkmen A, Oguz F, Kekik C, Ozdilli K, Nane I, Aydin F, Carin M. WITHDRAWN: Influence of Cytokine Gene Polymorphisms on Graft Rejection in Turkish Patients with Renal Transplants from Living Related Donors. Transplant Proc 2012; 44:1670-8. [DOI: 10.1016/j.transproceed.2012.05.046] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
16
|
Seyhun Y, Ozdilli K, Oguz F, Karahan G, Onal E, Turkmen A, Eldegez U, Nane I, Çalişkan Y, Bakkaloglu H, Carin M. Human Leukocyte Antigen and Major Histocompatibility Complex Class I-Related Chain A Antibodies After Kidney Transplantation in Turkish Renal Transplant Recipients. Transplant Proc 2012; 44:1660-6. [DOI: 10.1016/j.transproceed.2012.04.018] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
17
|
Seyhun Y, Mytilineos J, Turkmen A, Oguz F, Kekik C, Ozdilli K, Nane I, Aydin F, Carin M. Influence of Cytokine Gene Polymorphisms on Graft Rejection in Turkish Patients with Renal Transplants from Living Related Donors. Transplant Proc 2012; 44:1241-9. [DOI: 10.1016/j.transproceed.2012.01.125] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/23/2011] [Accepted: 01/31/2012] [Indexed: 11/25/2022]
|
18
|
Unuvar E, Tamay Z, Yildiz I, Toprak S, Kilic A, Aydin S, Kilic G, Guler N, Oguz F, Sidal M. Effectiveness of erdosteine, a second generation mucolytic agent, in children with acute rhinosinusitis: a randomized, placebo controlled, double-blinded clinical study. Acta Paediatr 2010; 99:585-9. [PMID: 20055782 DOI: 10.1111/j.1651-2227.2009.01646.x] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
AIM To evaluate whether mucolytic agents have an adjuvant role with antibiotics in the treatment of children with rhinosinusitis. METHODS Ninety-two children with rhinosinusitis were recruited for this randomized, placebo controlled, double-blinded clinical trial. Mean age was 8.5 +/- 3.2 years. Erdosteine (5-8 mg/kg/day) was administered to 49 children, and 43 children received placebo. Changes in symptoms were recorded with the standard S5 scoring for 14 days. Complete resolution of symptoms on day 14 was considered to be clinical improvement. RESULTS Eighty-one participants completed the study. Forty-one were in the treatment group and 40 in the placebo group. The average S5 scoring value at the onset of study was 11.0 in treatment group and 12.1 in placebo group. On day 14, mean scores were 3.1 in the treatment group and 2.8 in the placebo group. Complete improvement was 78% in the treatment group and 74.4% in the placebo group. There was no significant difference between the groups. There were no clinically detected serious side effects or complications in both groups. CONCLUSION Use of erdosteine as a mucolytic agent in children with acute rhinosinusitis does not directly affect the success of treatment.
Collapse
Affiliation(s)
- E Unuvar
- Department of Pediatrics, Istanbul School of Medicine, Istanbul University, Capa, Istanbul, Turkey.
| | | | | | | | | | | | | | | | | | | |
Collapse
|
19
|
Aydin F, Oguz F, Onal AE, Bilgen H, Oguz R, Anak S, Carin M, Gedikoglu G. FISH detection of chimerism in pediatric hematopoietic stem cell transplantation. Int J Lab Hematol 2007; 29:208-14. [PMID: 17474899 DOI: 10.1111/j.1751-553x.2007.00865.x] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
Allogeneic hematopoietic stem cell transplantation (HSCT) is a well-established curative therapy for various malignant and non-malignant diseases. Successful outcome after allogeneic HSCT has been associated with donor chimerism (DC). However, the detection of residual host cells or mixed hemopoietic chimerism (MC) has indicated that donor chimerism is not obligatory following HSCT. More recently, fluorescence in situ hybridization (FISH) analysis has been applied to engraftment studies for the identification of polymorphic or sex chromosomes. In this study, chimerism status was evaluated in 48 sex-mismatched HSCT pediatric patients (17 women/31 men, mean age: 9.02 +/- 3.95 years, range: 2-19) by FISH and the effect of DC or MC on outcome and long-term disease-free survival was documented. The stem cell source was bone marrow in all cases. All of the donors were human leucocyte antigen-identical siblings. FISH was performed on 156 specimens between days +13 and +1878. Donor chimerism was found in 47.9% (23/48) and MC was found in 52.1% (25/48) of the patients. Fifteen of 48 (31.25%) patients died, of whom 12 (80%) were MC and three patients (20%) were DC. The difference in chimerism status (MC or DC) was statistically significant between those patients who died and those still alive (chi(2) = 6.813; P = 0.009).
Collapse
Affiliation(s)
- F Aydin
- Department of Medical Biology, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey.
| | | | | | | | | | | | | | | |
Collapse
|
20
|
Abstract
We sought an association between certain human leucocyte antigen (HLA) markers and Graves' disease (GD) with and without ophthalmopathy (OP). One hundred and thirty-one Turkish patients with GD (50 without OP, 81 with OP) and 250 local healthy controls were studied. HLA-DRB1 typing was performed by using polymerase chain reaction-sequence-specific primers (PCR-SSP) method. The frequencies of DRB1*03 was significantly increased in GD compared to controls (OR = 2.07; 95% CI = 1.24-3.44), whereas DRB1*13 (OR = 0.33; 95% CI = 0.18-0.61) and DRB1*07 (OR = 0.31; 95% CI = 0.13-0.70) were significantly increased in controls compared to patients. None of the three associations showed any specificity to the OP group.
Collapse
Affiliation(s)
- S Yarman
- Department of Internal Medicine, Istanbul Medical Faculty, Istanbul University, Turkey
| | | | | |
Collapse
|
21
|
Kudat H, Telci G, Sozen AB, Oguz F, Akkaya V, Ozcan M, Atilgan D, Carin M, Guven O. The role of HLA molecules in susceptibility to chronic rheumatic heart disease. Int J Immunogenet 2006; 33:41-4. [PMID: 16426242 DOI: 10.1111/j.1744-313x.2006.00562.x] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
Only a small fraction of the streptococcal pharyngitis progress to rheumatic carditis, which implies that environmental, host and microbial factors interact to cause an aberrant immune response against the antigens of the microorganism that cross-react with cardiac tissues. Although there are numerous studies and a general consensus on the relation between human leucocyte antigen (HLA) class II antigens and rheumatic heart disease (RHD), the details and the culprit antigens are still controversial. The study was undertaken to examine 100 patients with chronic RHD and 100 controls for HLA class I and class II antigens for differences in prevalence. All samples were typed at the HLA-DRB1/3/4/5 and DQB1 loci by the sequence-specific primer (PCR-SSP) method at low resolution. For HLA class I antigens, HLA-B13 frequency was marginally increased in patients with RHD compared to controls without reaching statistical significance. For class II antigens, RHD patients had higher frequencies for HLA-DRB1*01 (RHD 24%, controls 10%), DRB1*04 (RHD 35%, controls 26%), DRB1*07 (RHD 18%, controls 11%) and HLA-DQB1*02 (RHD 32%, controls 17%) without reaching statistical significance, and significantly lower frequencies for DRB1*13 (Pc < 0.003, OR: 5.69), DRB5* (Pc < 0.003, OR: 33) and DRB3* (Pc = 0.03, OR: 2.66) compared to controls. It was concluded that host, microbial and environmental factors collude to create acute rheumatic fever (RF) and chronic rheumatic valve disease. The HLA-DRB1*13, DRB5* and DRB3* were protective against the development of rheumatic valve damage.
Collapse
Affiliation(s)
- H Kudat
- Department of Cardiology, Istanbul Faculty of Medicine, Istanbul University, Capa, Istanbul, Turkey
| | | | | | | | | | | | | | | | | |
Collapse
|
22
|
Abstract
Congenital erythropoietic porphyria (Gunther disease, CEP) is a rare autosomal recessive disorder of haeme biosynthesis. It is characterized by extreme photosensitivity and the excretion of large amounts of uroporphyrin I and coproporphyrin I in the urine and coproporphyrin I in the faeces. We have diagnosed two cases of congenital erythropoietic porphyria, who were first cousins once removed. They had recurrent skin bullae, scarring on the face and hands, hirsutism, discoloured fluorescent teeth, red urine, increased haemolysis and grossly increased excretion of porphyrin. Both children had blepharitis and their sclera gave pink fluorescence under long wave ultraviolet light, mainly in the interpalpebral fissures. All the features of our two patients, except the ocular lesions, conformed to cases of CEP reported in the literature. We have encountered no other reports on ocular lesions in CEP since first described by Chumbley in 1977.
Collapse
Affiliation(s)
- F Oguz
- Department of Paediatrics, University of Istanbul, Faculty of Medicine, Turkey
| | | | | | | | | |
Collapse
|